intranasal corticosteroids – Asian Pacific Journal of Allergy and Immunology

HOME
ABOUT
EDITORS
SUBMISSION
- Online Submission
- Author Instructions
ISSUE
PERMISSIONS
CONTACT
ADVERTISE

intranasal corticosteroids

November 28, 2024

Medication adherence, sensory attributes, and adverse effects of intranasal corticosteroids in allergic rhinitis patients: A systematic review and meta-analysis

Intranasal corticosteroid (INCS) remains the primary treatment for allergic rhinitis (AR). Understanding adherence, safety concerns and sensory preferences is crucial for optimal care.

adverse effects, Allergic rhinitis, intranasal corticosteroids, medication adherence, patient preference

October 15, 2023

Meta-analysis and cost-effectiveness analysisof intranasal corticosteroid treatment in allergic rhinitiswith ocular symptoms

Intranasal corticosteroid (INCS) has a beneficial effect on ocular symptoms in allergic rhinitis (AR). To our knowledge, the cost-effectiveness of available INCS for AR with ocular symptoms is yet to be demonstrated.

Allergic rhinitis, cost-effectiveness, economic evaluation, intranasal corticosteroids, ocular symptom

Key words

allergen Allergic rhinitis Allergy Anaphylaxis anxiety Asthma atopic dermatitis child Children Chlorhexidine chronic rhinosinusitis chronic spontaneous urticaria Chronic Urticaria COVID-19 cytokine depression diagnosis drug allergy Drug hypersensitivity efficacy Epidemiology food allergy house dust mite IgE Immunotherapy obstructive sleep apnea Omalizumab prevalence primary immunodeficiency Quality of life Questionnaire Reliability risk factor risk factors safety SARS-CoV-2 Sensitization Severe asthma Skin prick test Specific IgE Thai treatment urticaria vaccine Vitamin D

Support Contact

Managing Editor
Ms. Patrawadee Pitakpolrat
E-mail: managingeditor@apjai-journal.org

Production Editor
Ms. Chanita Jangsawang
E-mail: chanita.j@apjai-journal.org